Resolvyx Pharmaceuticals announced promising results for patients that suffer from dry eye syndrome during Phase 2 of a new class of anti-inflammatory medications. RX-10045, as it is now called, is a resolvin compound administered as an eye drop. In a 28 day study patients reported improved symptoms and the doctors reported a statistically significant improvement in the patients dry eyes. The entire press release is available on the Resolvyx Pharmaceuticals website. This is great news for patients that suffer from dry eyes. This is one of many medications on the horizon for the pharmaceutical treatment of dry eyes.
Visit the Total Eye Care Website
An Eye Doctor Answers Now Available on Amazon.com
- Today is Rare Disease Day. Keratoconus is a rare disease often encountered by eye doctors. One of the first questio… twitter.com/i/web/status/1… 2 months ago
- Due to an outage with our phone company, our phones are currently down. Spectrum is working on the problem and serv… twitter.com/i/web/status/1… 3 months ago
- facebook.com/TotalEyeCareCo… 3 months ago
May 2019 S M T W T F S « Jun 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
- Admin children computer Computer Vision contact lens Cornea dry eye dry eye syndrome Ehlers-Danlos emergency examinations eye eyecare Eye Care Eye Lids FAQ Glaucoma LASIK Low Vision Macular Degeneration Optic Nerve optometrist orthokeratology press release Refractive issues Retina Sites We like Technology video Vision